Cargando…
Role of imaging for eligibility and safety of a-NGF clinical trials
Nerve growth factor (a-NGF) inhibitors have been developed for pain treatment including symptomatic osteoarthritis (OA) and have proven analgesic efficacy and improvement in functional outcomes in patients with OA. However, despite initial promising data, a-NGF clinical trials focusing on OA treatme...
Autores principales: | Roemer, Frank W., Hochberg, Marc C., Carrino, John A., Kompel, Andrew J., Diaz, Luis, Hayashi, Daichi, Crema, Michel D., Guermazi, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240557/ https://www.ncbi.nlm.nih.gov/pubmed/37284331 http://dx.doi.org/10.1177/1759720X231171768 |
Ejemplares similares
-
Strategic application of imaging in DMOAD clinical trials: focus on eligibility, drug delivery, and semiquantitative assessment of structural progression
por: Guermazi, Ali, et al.
Publicado: (2023) -
Latest advancements in imaging techniques in OA
por: Hayashi, Daichi, et al.
Publicado: (2022) -
Early knee OA definition–what do we know at this stage? An imaging perspective
por: Li, Xiaojuan, et al.
Publicado: (2023) -
Efficacy and safety of biologic agents for the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials
por: Meng, Fanqiang, et al.
Publicado: (2022) -
Evaluation of local tissue peri-implant reaction in total knee arthroplasty failure cases
por: Brozovich, Ava, et al.
Publicado: (2022)